Abstract: A lid component for use with a glass jar and band of a mason jar, and a fermentation kit comprising these components. The lid component is made of an air-impermeable material and is dimensioned and configured to be releasably attachable to the jar by the band and to seal the wide mouth opening of the glass jar in an air-tight manner. The lid component further comprises a one-way valve adapted to allow gas produced by a fermentation process occurring inside the jar to escape from the jar while, at the same time, prevent oxygen-containing air from entering the jar, when the lid component is releasably attached to the jar.

Abstract: A method for producing substantially dendritic snow includes: a) supplying a flow of humid air (1) and a flow of cold air (9) into a substantially closed space (15, 16, 17) to mix the two air flows and create an atmosphere oversaturated with water within the space; b) forming ice crystals and allowing snowflakes to grow from the oversaturated atmosphere, keeping the ice crystals and growing snowflakes floating within the space and allowing them to grow over a predetermined period of time sufficiently long to obtain snowflakes having a predefined size, the floating condition being achieved by moving the ice crystals and growing snowflakes, on average, along a substantially helical trajectory by the air flow, which results in the snowflakes being distributed according to their size along the substantially helical trajectory; and c) thereafter releasing the predefined size snowflakes via a release opening (7) of the space by a carrier air flow (3).

Abstract: The present invention refers to human antibodies which are directed against ?-Synuclein (?-Syn) and their use in medicine and diagnosis.

Abstract: The present invention refers to human antibodies which are directed against ?-Synuclein (?-Syn) and their use in medicine and diagnosis.

Abstract: Isolated, monoclonal, human, anti-?-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an A? polypeptide comprising A?(21-37) shield A?(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formulation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided.

Abstract: A method, particularly an enzyme-linked immunosorbent assay (ELISA), for the in-vitro detection of A? autoantibodies in human serum and/or plasma contains the following steps: preparing an antigen-coated solid phase; incubating the solid phase with a blocking solution; incubating the solid phase with a sample to be examined; immunological detection of the A? autoantibodies on the solid phase; and reading the detected results of the solid phase using a reading tool. According to the invention, the preparation of the antigen-coated solid phase advantageously includes incubating the solid phase with a coating solution in which the antigen is dissolved, said antigen having a peptide sequence selected from the group SEQ ID No. 1, SEQ ID No. 2 or SEQ ID No. 3.

Abstract: The present invention refers to human antibodies which are directed against ?-Synuclein (?-Syn) and their use in medicine and diagnosis.

Abstract: A method for producing substantially dendritic snow includes: a) supplying a flow of humid air (1) and a flow of cold air (9) into a substantially closed space (15, 16, 17) to mix the two air flows and create an atmosphere oversaturated with water within the space; b) forming ice crystals and allowing snowflakes to grow from the oversaturated atmosphere, keeping the ice crystals and growing snowflakes floating within the space and allowing them to grow over a predetermined period of time sufficiently long to obtain snowflakes having a predefined size, the floating condition being achieved by moving the ice crystals and growing snowflakes, on average, along a substantially helical trajectory by the air flow, which results in the snowflakes being distributed according to their size along the substantially helical trajectory; and c) thereafter releasing the predefined size snowflakes via a release opening (7) of the space by a carrier air flow (3).

Abstract: Isolated, monoclonal, human, anti-?-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an A? polypeptide comprising A?(21-37) shield A?(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided.

Abstract: Isolated, monoclonal, human, anti-?-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an A? polypeptide comprising A?(21-37) shield A?(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formulation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided.

Abstract: Isolated, monoclonal, human, anti-?-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an A? polypeptide comprising A?(21-37) shield A?(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided.

Abstract: A method performs an operation for utilizing programming interface functionality of a first domain for accessing a remote resource of a second domain different than the first domain. Thereafter, the method performs an operation for providing the remote resource to a system having requested the remote resource. Provide the remote resource includes providing the remote resource through the first domain utilizing client-side services of said programming interface functionality.

Abstract: Isolated, monoclonal, human, anti-?-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an A? polypeptide comprising A?(21-37) shield A?(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided.